| Tu propio destinoFebruary 28 2007 at 8:18 AM No score for this post | Monica Lawinski (no login) |
| Noticero:
Segun la la informacion de Radio Murmansk, hoy durante la noche en la Ciudad Nuclear Bushel del Imperio Matamoros, nacio un varon, origen japones.
El varon tiene piel rosada, ojos gris, y le gusta mirar al cielo.
Es muy inteligente y sus primera palabras en espanol eran : Vamos al Circus.
Como la madre declaro que no sabe en que estacion de la linea 147 vive el padre, declaro que "El Benny" es el papa del varon.
Los medicos, despues de hablar con la prensa extranjera, recibieron un certificado de Los Van Van.
Este acto paso al las 15.35 hora local de Antigua y Barbuda.
|
| | Autor | Reply | Anonymous (no login) | Re: Tu propio destinoNo score for this post | February 28 2007, 12:18 PM |
Corporate Citizenship
Welcome to the Corporate Citizenship webpages for Eli Lilly and Company, our web-based report on the environmental, social, and economic aspects of our products and operations.
Corporate citizenship reporting is an important expression of our commitment to transparency and accountability and a tool for dialogue with our stakeholders. We hope you find this report valuable. Our approach to reporting is evolving, and we welcome your feedback. We have tried to make this report more relevant to users by focusing on the key issues associated with our business and our role in society.
A separate summary report, focusing on five of these key corporate citizenship issues, is available as a PDF (930kb). This web report, also available as a PDF (1384 kb), includes the content of the summary report and additional information to provide a comprehensive picture of our business and our corporate citizenship performance.
This report has three main sections. The first provides our chairman’s perspective on corporate citizenship; a profile of our business, products, and issues; and discussion of our approach to corporate citizenship, including stakeholder engagement, our governance systems, and our Code of Conduct.
The second section reviews our approach and performance relative to the following key issues:
Research and Development, including clinical trial disclosure and animal research
Ethical Marketing and Use, including promotion of pharmaceuticals and patient safety
Access to Medicines
Investing in Our Communities, including global examples of philanthropy and community involvement
Protecting Health, Safety and the Environment, including our management systems, product life cycle approach, and performance
Workforce and Workplace, including our employment philosophy and approach to training and development and human rights
Supply Chain, including supplier diversity and auditing suppliers
Public Policy, including political lobbying and contributions.
The third section summarizes the awards and recognition Lilly has received. More information about our corporate citizenship reporting is available here.
Chairman's Letter
Our Business
Corporate Citizenship Approach
Key Issues
Awards and Recognition
| |
| | Current Topic - Tu propio destino |
| |
|
|